Document:

Exhibit 10(iv)

 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS.
SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED
AND REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURITIES LAWS OR UNLESS, IN THE OPINION OF COUNSEL REASONABLY SATISFACTORY
TO THE COMPANY, SUCH QUALIFICATION AND REGISTRATION ARE NOT REQUIRED. ANY TRANSFER OF THE SECURITIES REPRESENTED BY THIS NOTE IS
FURTHER

 

SUBJECT TO OTHER RESTRICTIONS, TERMS AND
CONDITIONS WHICH ARE SET FORTH HEREIN.

 

Principal Amount: $215,000 Issue Date:
August 4, 2020 Purchase Price: $200,000 Original Issue Discount: $15,000

 

ELECTROMEDICAL TECHNOLOGIES, INC. 8% CONVERTIBLE
PROMISSORY NOTE

 

FOR VALUE RECEIVED, pursuant to the terms
and conditions of this 10% Convertible Promissory Note (this "Note"), Electromedical Technologies, Inc., a Delaware corporation
(the "Company"), hereby promises to pay to the order of JR-HD Enterprises III, LLC, a Delaware limited liability company,
or registered assigns (the "Holder'"), on the first anniversary of the Issue Date as set forth above or earlier as required
pursuant to the Agreement, as defined below (as applicable, the "Maturity Date"), the sum of $215,000 (the "Principal
Amount"), and to pay interest on the outstanding Principal Amount at the rate of eight percent (8%) per annum, simple interest,
in each case to the extent that this Note and the Principal Amount and any accrued interest hereunder (the "Indebtedness")
has not been converted into Conversion Shares (as defined below) prior to the Maturity Date. Interest shall commence accruing on
the date hereof (the "Issue Date"), computed on the basis of a 365-day year and the actual number of days elapsed, and
shall be payable as set forth herein.

 

This Note carries an original issue discount
of $15,000 (the "OID"), to cover the Holder's accounting fees, due diligence fees, monitoring, and/or other transactional
costs incurred in connection with the purchase and sale of the Note, which is included in the principal balance of this Note. Thus,
the purchase price of this Note shall be $200,000, computed as follows: The Principal Amount minus the OID.

 

This Note is entered into pursuant to a
Note Purchase Agreement by and between the Company and the Holder dated as of the Issue Date (the "Agreement") and is
subject to the terms and conditions thereof.

 

This Note is not a certificate of deposit
or similar obligation of, and is not guaranteed or insured by, any depository institution, the Federal Deposit Insurance Corporation,
the Securities Holder Protection Corporation or any other governmental or private fund or entity.

 

    1

     

    

 

The following terms shall apply to this
Note:

 

Section 1. Definitions. Defined terms used
herein without definition have the meanings given them in the Agreement. Section 2. Interest; Late Fees: Prepayment.

 

(a) To the extent not converted to Conversion
Shares (as defined below) prior to the Maturity Date, the Principal Amount and accrued and unpaid interest shall be due and payable
in full on the Maturity Date. No payments of the Principal Amount or interest herein shall be required prior to the Maturity Date.

 

(b) The Company may prepay all or any portion
of the Principal Amount and any accrued and unpaid interest at any time subject to, and with, a 20% prepayment cost being added
to the amount of the Principal Amount and accrued and unpaid interest so prepaid at such time.

 

(c) Interest on this Note shall accrue
on a simple interest, non-compounded basis, and shall be added to the Principal Amount on the Maturity Date or such earlier date
as the Indebtedness may be paid hereunder or may be due hereunder pursuant to the terms herein, at which time all Indebtedness
shall be due and payable, unless earlier converted into Conversion Shares. In the event that any amount due hereunder is not paid
as and when due, such amounts shall accrue interest at the rate of 18% per year, simple interest, non-compounding, until paid.

 

(d) Whenever any payment or other obligation
hereunder shall be due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day.

 

Section 3. Conversion.

 

(a) Conversion Right. Subject to the terms
and conditions herein, the Holder shall have the right from time to time, and at any time following the six month anniversary of
the Issue Date and ending on the full repayment of all Indebtedness (the "Conversion Period), to convert all or any part of
the Indebtedness into fully paid and non-assessable shares of Common Stock, or any shares of capital stock or other securities
of the Company into which such Common Stock shall hereafter be changed or reclassified (as applicable, the "Conversion Shares")
at the Conversion Price as defined and as the same may be adjusted pursuant to Section 3(b) (a "Conversion"); provided,
however, that in no event shall the Holder be entitled to convert any portion of this Note in excess of that portion of this Note
upon conversion of which the sum of (1) the number of shares of Common Stock beneficially owned by the Holder and its affiliates
(other than shares of Common Stock which may be deemed beneficially owned

 

through the ownership of the unconverted
portion of the Note or the unexercised or unconverted portion of any other security of the Company subject to a limitation on conversion
or exercise analogous to the limitations contained herein) and (2) the number of shares of Common Stock issuable upon the conversion
of the portion of this Note with respect to which the determination of this proviso is being made, would result in beneficial ownership
by the Holder and its affiliates of more than 9.99% of the outstanding shares of Common Stock. For purposes of the proviso to the
immediately preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d) of the Securities Exchange
Act of 1934, as amended (the "Exchange Act"), and Regulations 13D-G thereunder, except as otherwise provided in clause
(1) of such proviso, provided, further, however, that the limitations on conversion may be waived by the Holder upon, at the election
of the Holder, not less than 61 days' prior notice to the Company, and the provisions of the conversion limitation shall continue
to apply until such 61" day (or such later date, as determined by the Holder, as may be specified in such notice of waiver).
The number of Conversion Shares to be issued upon each conversion of this Note shall be determined by dividing the Indebtedness
by the applicable Conversion Price then in effect on the date specified in the notice of conversion, in the form attached hereto
as Exhibit A (the "Notice of Conversion"), delivered to the Company by the Holder in accordance with the provisions herein.

 

    2

     

    

 

(b) Conversion Price; Adjustment.

 

(i) The conversion price (the "Conversion
Price') shall initially mean $0.50, provided that such Conversion Price shall be subject to adjustment or revision as set forth
herein.

 

(ii) The Conversion Price, as the same
may have already been adjusted, shall be subject to equitable adjustments for stock splits, stock dividends or rights offerings
by the Company relating to the Company's securities or the securities of any subsidiary of the Company, combinations, recapitalization,
reclassifications, extraordinary distributions and similar events that occur on or after the Issue Date. By way of example and
not limitation, in the event of forward split of the Common Stock following such applicable time in which each share of Common
Stock is converted into two shares of Common Stock, the Conversion Price shall be reduced by 50%, and in the event of a reverse
split of the Common Stock following such applicable time in which each two shares of Common Stock are converted into one share
of Common Stock, the Conversion Price shall be increased by 100%.

 

(c) Mechanics of Conversion. Subject to
the provisions of this Section 3, this Note may be converted by the Holder in whole or in part at any time from time to time during
the Conversion Period by (A) submitting to the Company a Notice of Conversion (by facsimile, e-mail or other reasonable means of
communication dispatched prior to 6:00 p.m., New York, New York time) and (B) subject to Section 3(c), surrendering this Note at
the principal office of the Company. The conversion shall be effective as of the date of delivery of the Notice of Conversion by
the time as set forth above (the "Conversion Date"), provided that if the Notice of Conversion is not delivered by such
time then the Conversion Date shall be the next Business Day and the Notice of Conversion shall be deemed automatically updated
accordingly.

 

(d) Surrender of Note Upon Conversion.
Notwithstanding anything to the contrary set forth herein, upon conversion of this Note in accordance with the terms hereof, the
Holder shall not be required to physically surrender this Note to the Company unless the entire unpaid amount of Indebtedness is
so converted. The Holder and the Company shall maintain records showing the amount of Indebtedness so converted and the dates of
such conversions or shall use such other method, reasonably satisfactory to the Holder and the Company, so as not to require physical
surrender of this Note upon each such conversion. In the event of any dispute or discrepancy, such records of the Company shall,
prima facie, be controlling and determinative in the absence of manifest error. Notwithstanding the foregoing, if any portion of
this Note is converted as aforesaid, the Holder may not transfer this Note unless the Holder first physically surrenders this Note
to the Company, whereupon the Company will forthwith issue and deliver upon the order of the Holder a new Note of like tenor, registered
as the Holder (upon payment by the Holder of any applicable transfer taxes) may request, representing in the aggregate the remaining
unpaid Indebtedness of this Note. The Holder and any assignee, by acceptance of this Note, acknowledge and agree that, by reason
of the provisions of this paragraph, following conversion of a portion of this Note, the unpaid and unconverted principal amount
of this Note represented by this Note may be less than the amount stated on the face hereof.

 

    3

     

    

 

(e) Payment of Taxes. The Company shall
not be required to pay any tax which may be payable in respect of any transfer involved in the issue and delivery of Conversion
Shares or other securities or property on conversion of this Note in a name other than that of the Holder (or in street name),
and the Company shall not be required to issue or deliver any such Conversion Shares or other securities or property unless and
until the person or persons (other than the Holder or the custodian in whose street name such shares are to be held for the Holder's
account) requesting the issuance thereof shall have paid to the Company the amount of any such tax or shall have established to
the satisfaction of the Company that such tax has been paid. (f) Delivery of Common Stock Upon Conversion. Upon receipt by the
Company from the Holder of the Notice of Conversion meeting the requirements for conversion as provided in this Section 3, the
Company shall issue and deliver or cause to be issued and delivered to or upon the order of the Holder certificates for the Conversion
Shares issuable upon such conversion within three (3) Business Days after such receipt (and, solely in the case of conversion of
the entire unpaid principal amount hereof, surrender of this Note) in accordance with the terms hereof and the Agreement. Upon
receipt by the Company of a Notice of Conversion, the Holder shall be deemed to be the holder of record of the Conversion Shares
issuable upon such conversion, the outstanding principal amount and the amount of accrued and unpaid interest on this Note shall
be reduced to reflect such conversion, and, unless the Company defaults on its obligations under this Section 3, all rights with
respect to the portion of this Note being so converted shall forthwith terminate except the right to receive the Conversion Shares
or other securities, cash or other assets, as herein provided, on such conversion. If the Holder shall have given a Notice of Conversion
as provided herein, the Company's obligation to issue and deliver the certificates (subject to the provisions of Section 3(g))
for Conversion Shares shall be absolute and unconditional, irrespective of the absence of any action by the Holder to enforce the
same, any waiver or consent with respect to any provision thereof, the recovery of any judgment against any person or any action
to enforce the same, any failure or delay in the enforcement of any other obligation of the Company to the holder of record, or
any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder of any obligation
to the Company, and irrespective of any other circumstance which might otherwise limit such obligation of the Company to the Holder
in connection with such conversion.

 

(g) Delivery of Common Stock by Electronic
Transfer. In lieu of delivering physical certificates representing the Conversion Shares issuable upon conversion, provided the
Company is participating in the Depository Trust Company ("DTC") Fast Automated Securities Transfer ("FAST")
program, upon request of the Holder and its compliance with the provisions contained in this Section 3, the Company shall use its
reasonable efforts to cause its transfer agent to electronically transmit the Conversion Shares issuable upon conversion to the
Holder by crediting the account of Holder's Prime Broker with DTC through its Deposit Withdrawal Agent Commission ("DWAC")
system.

 

    4

     

    

 

(h) Adjustment Due to Merger, Consolidation,
Etc. If, at any time when this Note is issued and outstanding and prior to full conversion of this Note, there shall be any merger,
consolidation, or an exchange of shares, recapitalization or reorganization pursuant to a merger or consolidation, or other similar
event, as a result of which shares of Common Stock of the Company shall be changed into the same or a different number of shares
of another class or classes of stock or securities of the Company or another entity, or in case of any sale or conveyance of all
or substantially all of the assets or more than 50% of the total outstanding shares of the Company other than in connection with
a plan of complete liquidation of the Company, then the Holder of this Note shall thereafter have the right to receive upon conversion
of this Note, upon the basis and upon the terms and conditions specified herein and in lieu of the Conversion Shares immediately
theretofore issuable upon conversion, such stock, securities or assets which the Holder would have been entitled to receive in
such transaction had this Note been converted in full immediately prior to such transaction (without regard to any limitations
on conversion set forth herein), and in any such case appropriate provisions shall be made with respect to the rights and interests
of the Holder of this Note to the end that the provisions hereof (including, without limitation, provisions for adjustment of the
Conversion Price and of the number of shares issuable upon conversion of the Note) shall thereafter be applicable, as nearly as
may be practicable in relation to any securities or assets thereafter deliverable upon the conversion hereof.

 

(i) Status as Shareholder. Subject to the
terms and conditions herein, upon submission of a Notice of Conversion by the Holder, (i) this Note shall be deemed converted into
Conversion Shares and (ii) the Holder's rights as the holder of this Note shall cease and terminate, excepting only the right to
receive the Conversion Shares as set out herein and to any remedies provided herein or otherwise available at law or in equity
to such Holder because of a failure by the Company to comply with the terms of this Note.

 

Section 4. Events of Default.

 

(a) The Holder may elect to declare an
"Event of Default" if any of the following conditions or events shall occur and be continuing:

 

(i) the Company fails to pay the then-outstanding
principal amount and accrued interest on this Note on any date any such amounts become due and payable, and any such failure is
not cured within three Business Days of written notice thereof by Holder;

 

(ii) any representation or warranty of
the Company is materially false or untrue when given;

 

(iii) the Company fails to comply in any
material respect with any other covenant or agreement in this Note or in the Agreement and any such failure is not cured within
three Business Days of written notice thereof by Holder;

 

(iv) the Company fails to remain compliant
with the Depository Trust Company ("DTC"), thus incurring a "chilled" status with DTC;

 

    5

     

    

 

(v) the Company fails to satisfy its filing
or disclosure obligations under Securities Act, the Exchange Act or the rules and guidelines issued by OTC Markets News Service,
OTCMarkets.com and their affiliates;

 

(vi) any trading suspension imposed by
the United States Securities and Exchange Commission under Section 12(j) of the Exchange Act or Section 12(k) of the Exchange Act;

 

(vii) the occurrence of any delisting of
the Common Stock from the Primary Trading Market or suspension of trading of the Common Stock on the Trading Market;

 

(viii) the Company fails remain in good
standing under the laws of the State of Delaware;

 

(ix) the Company shall (i) apply for or
consent to the appointment of, or the taking of possession by, a receiver, custodian, trustee or liquidator; (ii) make a general
assignment for the benefit of the Company's creditors; or (iii) commence a voluntary case under the U.S. Bankruptcy Code as now
and hereafter in effect, or any successor statute; or a proceeding or case shall be commenced, without the application or consent
of the Company, in any court of competent jurisdiction, seeking (1) liquidation, reorganization or other relief with respect to
it or its assets or the composition or readjustment of its debts, or (2) the appointment of a trustee, receiver, custodian, liquidator
or the like of any substantial part of its assets, and, in each case, such proceedings or case shall continue undismissed, or an
order, judgment or decree approving or ordering any of the foregoing shall be entered and continue unstayed and in effect, for
a period of 60 days, if in the United States, or 90 days, if outside of the United States;

 

(x) or an order for relief against the
Company shall be entered in an involuntary case under any bankruptcy, insolvency, composition, readjustment of debt, liquidation
of assets or similar Law of any jurisdiction.

 

(b) Consequences of Events of Default.
If an Event of Default has occurred and is continuing (i) the Holder may, by notice to the Company, declare all or any portion
of the then outstanding principal amount of the Note, together with all accrued and unpaid interest thereon, due and payable, and
the Note shall thereupon become, immediately due and payable in cash and (ii) the Holder shall have the right to pursue any other
remedies that the Holder may have under applicable Law.

 

Section 5. Miscellaneous.

 

(a) Notices. Any and all notices or other
communications or deliveries to be provided hereunder shall be given in accordance with the provisions of the Agreement.

 

(b) Lost or Mutilated Note. If this Note
shall be mutilated, lost, stolen or destroyed, the Company shall execute and deliver, in exchange and substitution for and upon
cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen or destroyed Note, a new Note so mutilated,
lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of this Note, and of the ownership
hereof reasonably satisfactory to the Company.

 

    6

     

    

 

(c) Governing Law. This Note, and all matters
based upon, arising out of or relating in any way to this Note, including all disputes, claims or causes of action arising out
of or relating to this Note as well as the interpretation, construction, performance and enforcement of this Note, shall be governed
by the laws of the United States and the State of Delaware, without regard to any jurisdiction's conflict-of-laws principles.

 

(d) Incorporation of Provisions. The provisions
of Article VI of the Agreement (Miscellaneous) of the Agreement shall apply to this Note as though fully set forth herein, provided
that each reference therein to the "Agreement" shall be deemed a reference to this Note. In the event of any conflict
between the terms of the Agreement and the terms of this Note, the terms of this Note shall control.

 

(e) Next Business Day. Whenever any payment
or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made on the next succeeding
Business Day.

 

(f) Entire Agreement. This Note (including
any recitals hereto) and the Agreement set forth the entire understanding of the parties with respect to the subject matter hereof,
and shall not be modified or affected by any offer, proposal, statement or representation, oral or written, made by or for any
party in connection with the negotiation of the terms hereof, and may be modified only by instruments signed by the Company and
the Holder.

 

(g) No_ Assignment by the Company. This
Note may not be assigned by the Company to any Person without the prior written consent of the Holder in its sole discretion.

 

(h) Currency. All dollar amounts are in
U.S. dollars.

 

[SIGNATURE PAGE FOLLOWS]

 

IN WITNESS WHEREOPF, the undersigned has
executed this Note as of the Issue Date.

 

Electromedical Technologies, Inc.

 

By: : Name: Matthe yf itoon Title: Chief
Executive Officer

 

Agreed and accepted:

 

JR-HD Enterprises III, LLC

 

By:

 

Name: Jeff Ramson Title: Manager

 

    7

     

    

 

EXHIBIT A NOTICE OF CONVERSION

 

The undersigned hereby elects to convert
the portion of the Indebtedness (as defined in the Note, as defined below) as set forth below pursuant to the convertible promissory
note (the "Note") of Electromedical Technologies, Inc., a Delaware corporation (together with any successor entity thereto,
the "Company") into that number of shares of Common Stock (as defined in the Note) to be issued pursuant to the conversion
of the Note and according to the conditions of the Note, as of the date written below.

 

The undersigned hereby requests that the
Company issue a certificate or certificates, or other permissible evidence of shares of Common Stock as set forth in the Note,
for the number of shares of Common Stock set forth below (which numbers are based on the Holder's calculation below and which shall
be confirmed by, and subject to acceptance by, the Company) in the name(s) specified immediately below or, if additional space
is necessary, on an attachment hereto:

 

Name: JR-HD Enterprises III, LLC

 

Address: Date of Conversion: Amount of
Indebtedness to be converted: $ Applicable Conversion Price: $ Number of shares of Common Stock to be Issued: shares of Common
Stock JR-HD Enterprises III, LLC

 

By: Name: Jeff Ramson Title: Manager

 

    8EX-10.1

 Exhibit 10.1 

SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS 
 This
Separation Agreement and General Release of Claims (“Agreement”) is made between Intel Corporation (“Intel” or the “Company”) and Dr. Venkata Renduchintala (“you”). In return for your promises in this
Agreement, Intel agrees to provide you severance pay and benefits described below. Accordingly, Intel and you understand and agree as follows: 

1.    Separation Date; Payments Upon Separation. You will separate from employment at Intel effective August 3,
2020 (the “Separation Date”). You will also immediately take all actions necessary to resign from any outside boards of director seats which you hold on behalf of Intel or as Intel’s representative. On the Separation Date, Intel will
pay you all accrued salary and any accrued, but unused vacation and sabbatical earned through the Separation Date, subject to payroll deductions and required withholdings. Except as provided below, your group health coverage will terminate on the
last day of the month in which your employment ends. At that time, you will be eligible to continue group health insurance benefits at your own expense under the terms and conditions of the applicable benefit plan and either federal COBRA law or, if
applicable, state insurance laws. 
 2.    Severance Benefits. Provided that you sign and do not revoke this
Agreement, you will receive: 
  

			
	a.	 	 Severance Pay. A severance payment of $1,800,000, which will be paid within twenty (20) days after this
Agreement’s Effective Date. This severance payment will be subject to applicable taxes and withholdings.

		
	b.	 	 Outplacement.   A payment of $22,500 for the use of executive outplacement services with Lee Hecht Harrison,
which will be paid within twenty (20) days after this Agreement’s Effective Date. This payment will be subject to applicable taxes and other withholdings.

		
	c.	 	 Healthcare Supplemental Payment. A payment of $21,192, which will be paid within twenty (20) days after this
Agreement’s Effective Date. This payment will be subject to applicable taxes and other withholdings.

 3.    Expense Reimbursement. You agree that, no later than the Separation Date,
you will submit your final expense reimbursement statement and required documentation reflecting all business expenses you incurred through that date, if any, for which you seek reimbursement. Intel will reimburse you for expenses pursuant to its
standard business practice. 
 4.    Other Compensation or Benefits. You acknowledge that, except as expressly
provided in this Agreement, you will not receive any additional compensation, equity, severance or benefits after the Separation Date, except for any benefit that has vested or will vest under the express terms of a written Company benefit, bonus,
equity, or retirement plan. 
 5.    Obligation to Protect Intel’s Confidential Information. You represent that
you have abided by your obligations not to disseminate or disclose Intel confidential or proprietary information and will continue to abide by these obligations. You acknowledge you have acquired knowledge of or had access to trade secrets and
confidential or other proprietary information of Intel Corporation, its subsidiaries, its customers and/or third parties (“Intel Confidential Information”) during the course of your employment at Intel. You acknowledge your ongoing
obligation to protect such information, as outlined in your Intel Employment Agreement and the Trade Secret Acknowledgment Form or as required under other Intel policies. You further agree to execute the Trade Secret Acknowledgment Form, and will
participate in exit interviews as requested by your management or Intel Legal. Notwithstanding the above, under the federal Defend Trade Secrets Act of 2016, you shall not be held criminally or civilly liable under federal or state trade secret law
for the disclosure of a trade secret that: (a) is made in confidence to an attorney or to a federal, state, or local government official, either directly or indirectly, and is solely for the purpose of reporting or investigating a suspected
violation of law; (b) is made to your attorney in relation to a lawsuit for retaliation against you for reporting a suspected violation of law; or (c) is made in a complaint or other document filed in a lawsuit or other proceeding filed by
you, if such document is filed (i) under seal in any lawsuit or proceeding, and (ii) pursuant to court order in any retaliation lawsuit filed by you. You agree that you will not use or disclose Intel Confidential Information at any time to
aid any third party to target, identify, and/or solicit Intel employees to leave Intel employment. 

  
 SEPARATION AGREEMENT AND GENERAL RELEASE OF
CLAIMS 

 6.    Return of Company Property and Confidential Information. You
have returned, or will, by the Separation Date, return to Intel any and all Intel property (files, documents, laptops, company-issued phones, tablets, keys, credit cards, etc.) and any and all Intel Confidential Information and property in your
possession. You certify that you have no Intel Confidential Information, including on any personal devices and accounts. 

7.    Departure Announcement. You agree that any e-mail or communication from
you announcing your departure from Intel or the reasons for it shall be pre-approved by your manager. 

8.    General Release of Claims. In exchange for the benefits and payments referenced in paragraph 2 above, you
release Intel (including its subsidiaries, affiliates, successors, and all of its and their past and present directors, officers, employees, agents, insurers and attorneys) (collectively “Releasees”) from all claims of any kind, known or
unknown, which arose on or before the day you signed this Agreement, except claims that cannot lawfully be waived. For example, you waive all contract, tort, or other common law claims you might have, claims for attorneys’ fees and other
litigation costs, claims under Title VII of the Civil Rights Act, the Equal Pay Act, the Age Discrimination in Employment Act, the Americans with Disabilities Act, the Family and Medical Leave Act, the Uniformed Services Employment and Reemployment
Rights Act, the Worker Adjustment and Retraining Notification Act, the Employee Retirement Income Security Act, the National Labor Relations Act, the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the California
Fair Employment and Housing Act, the California Family Rights Act, the California Labor Code, the Unruh Civil Rights Act, the California Equal Pay Law, the California Pregnancy Disability Leave Law, the California Military & Veterans Code,
California Industrial Commission Wage Orders, the California Constitution, the California Business and Professions Code, all of their amendments, and claims under other federal, state and local laws. The claims released also include, but are not
limited to, any benefits (except as provided in Paragraph 11 below) and/or unvested equity under any Intel plan, program, policy or practice. This Agreement includes a release of claims of discrimination or retaliation on the basis of workers’
compensation status, but does not include workers’ compensation claims. You also give up all rights to participate in a class, collective or representative action under any federal, state, or local law. 

9.    Release of Unknown Claims. You are intentionally releasing claims against Releasees of which you may be unaware.
If you work or reside in California, you acknowledge that you have read and understand Section 1542 of the California Civil Code, which states: “A general release does not extend to claims that the creditor or releasing party does not
know or suspect to exist in his or her favor at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party.” You give up all rights and benefits
under that section. You agree that this Release of Unknown Claims is fairly and knowingly made. 
 10.    No
Pending Lawsuits. You represent that you are not a complainant or a party in any pending lawsuit, civil action, charge or claim in any court or before any regulatory agency of any kind against Intel or any of its subisidiaries, divisions,
affiliated corporations, trustees, directors, officers, shareholders, owners, agents, attorneys, insurers, or employees.  

  
 SEPARATION AGREEMENT AND GENERAL RELEASE OF
CLAIMS 

 11.    Additional Release Exclusions/Employee Protections. This
Agreement does not affect your rights to receive vested retirement and pension plan benefits, medical plan benefits, or unemployment compensation benefits. Neither the Release provisions above nor anything else in this Agreement affects:
(i) claims that arise after the day on which you sign this Agreement, such as claims for breach of this Agreement; (ii) rights which as a matter of law cannot be released by private agreement, including your rights to file a charge with
any federal, state or local government agency, such as the U.S. Equal Employment Opportunity Commission, or to communicate with, provide information to, or participate in an investigation conducted by such an agency; or (iii) rights to testify
truthfully in a California legislative, judicial or administrative proceeding concerning alleged criminal conduct or sexual harassment by Intel or its agents or employees provided that such testimony is required by court order, subpoena, or a
written request from the California legislature. However, you are hereby waiving all rights to recover money or other individual relief from any Releasee should any agency or individual pursue a claim on your behalf. You may nonetheless accept money
from the U.S. Securities and Exchange Commission as a reward for providing information to that agency. 

12.    Employee Acknowledgements. You agree that: 

 

	 	(a)	 The value of the Severance Benefits described above exceeds in value any other pay and benefits you may be owed by Intel
apart from this Agreement. 

  

	 	(b)	 Intel is not obligated to provide you with the Severance Benefits described above apart from this Agreement.

  

	 	(c)	 You have carefully read and fully understand this Agreement. You are entering into this Agreement knowingly and
voluntarily, and intending to be bound by all of your promises herein. 

  

	 	(d)	 The Severance Benefits described above are conditioned on and subject to your continued compliance with Intel’s
policies and guidelines. 

  

	 	(e)	 You acknowledge that this Agreement is a “negotiated” severance agreement as defined by California law
(Government Code section 12964.5(c)(2) defines “negotiated” to mean the agreement is “voluntary, deliberate, and informed, provides consideration of value to the employee, and that the employee is given notice and an opportunity to
retain an attorney or is represented by an attorney”). 

 13.    Additional Employee
Acknowledgements. You further acknowledge that: (i) you have received all wages owed to you up through the last regular payroll cycle before you signed this Agreement, (ii) you have no known workplace injury or occupational illness
that arose out of your employment with Intel that you failed to report, (iii) you received during your employment with Intel all leave that you requested and for which you were eligible, (iv) it is Intel policy to encourage reporting
within Intel possible violations of any law by or on behalf of Intel, (v) no one interfered with your reporting of any such violations, and (vi) nothing in this Agreement shall prevent you from lawfully communicating to government
authorities possible violations of federal, state or local law or other information that is protected under the whistleblower provisions of federal, state or local law. 

14.    Nondisparagement. You promise not to make any statements or remarks, verbally or in writing, that disparage
Intel, its products or capabilities or any other Releasee (including its officers, directors, employees and agents) in any manner; however, you may respond accurately and fully to any question or request for information when required to do so by
law. You also agree not to encourage, directly or indirectly, any third party to sue the Company. Intel agrees to inform Robert Swan and George Davis of their obligation not to disparage you; provided that these individuals may respond accurately
and fully to any question or request for information when required to do so by law. 

  
 SEPARATION AGREEMENT AND GENERAL RELEASE OF
CLAIMS 

 15.    Cooperation Regarding Other Claims. If any claim is asserted
by or against Intel as to which you have relevant knowledge, you agree to reasonably cooperate with Intel in pursuing or defending that claim, including by providing truthful information and testimony as reasonably requested by Intel. You further
agree to cooperate and provide information to Intel in connection with any internal investigation as to which you have relevant knowledge. Intel agrees to reimburse you for reasonable
out-of-pocket expenses and reasonable travel costs incurred with providing such cooperation. 

16.    Right to Consult Legal Counsel. You have been advised in writing by this Agreement to consult with an attorney
before signing it, and have had an adequate opportunity to do so. 
 17.    Time To Consider and Revoke/Effective
Date. You have at least twenty-one (21) days from the date you received this Agreement to consider it before signing. Although you need not take all 21 days before signing, you must not sign the
Agreement before the Separation Date. You then have seven (7) days after signing this Agreement to revoke it (“Revocation Period”). This Agreement will not be effective until you have signed it and returned it to Julie Kwok in
Intel’s Legal Department and the Revocation Period has expired (the “Effective Date”). 
 18.    Deadline
to Accept. You understand that the offer reflected in this Agreement shall be withdrawn if the Agreement is not signed by you and returned to Julie Kwok in Intel’s Legal Department Intel by August 17, 2020. If Intel does not receive
your signed Agreement by that time, you will not be eligible for the payments or benefits described in this Agreement. You further understand that your employment with Intel will terminate regardless of whether you sign this Agreement. 

19.    Governing Law. This Agreement is entered into under California law, and shall be governed by California law
except to the extent federal law governs. 
 20.    Miscellaneous. This Agreement (including the agreements and
other documents referenced above) constitutes the complete, final and exclusive agreement between the parties regarding all subjects referenced herein. It is entered into without reliance on any promise or representation, written or oral, other than
those expressly contained herein, and it supersedes any other promises or representations. This Agreement may only be changed in a writing signed by both you and an authorized Intel representative. This Agreement will bind both parties’ heirs,
personal representatives, successors and assigns, and will inure to the benefit of both parties plus their heirs, successors and assigns. If any provision of this Agreement is determined by a court of competent jurisdiction to be invalid or
unenforceable, that determination will not affect any other provision and the provision in question will be modified by the court so as to be made enforceable. You agree that an electronically signed Agreement will have the same validity and
enforceability as if you signed the Agreement in handwriting. This Agreement is not an admission of fault or liability by either you or Intel. 
 IF THIS AGREEMENT
IS ACCEPTABLE TO YOU, PLEASE SIGN BELOW NO EARLIER THAN August 3, 2020 (THE “SEPARATION DATE”) AND RETURN THE ENTIRE, SIGNED AGREEMENT TO JULIE KWOK IN INTEL’S LEGAL DEPARTMENT. 

 

							
	Dr. Venkata Renduchintala	 		  	Date	  	
				
	 /s/ Dr. Venkata Renduchintala
	 		  	 8/11/2020
	  	

  
 SEPARATION AGREEMENT AND GENERAL RELEASE OF
CLAIMS

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}]]